Aptose Biosciences Inc. (APTO)
NASDAQ$3.76
Market Cap
$8.06M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
371 of 924
Rank in Industry
216 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
APTO Insider Trading Activity
APTO Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $20,000 | 1 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Rice William G. | Chair, President & CEO | 1 | $20,000 | 0 | $0 | $20,000 |
About Aptose Biosciences Inc.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops …
Insider Activity of Aptose Biosciences Inc.
Over the last 12 months, insiders at Aptose Biosciences Inc. have bought $20,000 and sold $0 worth of Aptose Biosciences Inc. stock.
On average, over the past 5 years, insiders at Aptose Biosciences Inc. have bought $165,712 and sold $1.43M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Rice William G. (Chair, President & CEO) — $20,000.
The last purchase of 100,000 shares for transaction amount of $20,000 was made by Rice William G. (Chair, President & CEO) on 2024‑11‑25.
List of Insider Buy and Sell Transactions, Aptose Biosciences Inc.
| 2024-11-25 | Rice William G. | Chair, President & CEO | 100,000 0.5592% | $0.20 | $20,000 | +1.27% | ||
| 2023-09-22 | Seizinger Bernd R. | director | 17,000 0.2389% | $3.14 | $53,380 | -50.66% | ||
| 2022-06-06 | Rice William G. | Chair, President & CEO | 10,000 0.0109% | $0.97 | $9,681 | -32.29% | ||
| 2021-12-20 | BURGER DENIS R | director | 10,000 0.0117% | $1.45 | $14,490 | -38.49% | ||
| 2021-12-16 | PLATZER ERICH | director | 100,000 0.1055% | $1.38 | $137,900 | -41.50% | ||
| 2021-12-16 | Rice William G. | Chair, President & CEO | 13,183 0.0153% | $1.52 | $20,038 | -41.50% | ||
| 2021-12-15 | PLATZER ERICH | director | 270,000 0.2989% | $1.17 | $316,340 | -27.73% | ||
| 2021-12-15 | Rice William G. | Chair, President & CEO | 17,822 0.0189% | $1.12 | $19,961 | -27.73% | ||
| 2021-11-26 | Rice William G. | Chair, President & CEO | 8,643 0.0098% | $2.31 | $19,965 | -57.89% | ||
| 2021-11-19 | Bejar Rafael | Sr. VP, Chief Medical Officer | 10,000 0.0115% | $2.56 | $25,600 | -59.76% | ||
| 2021-08-05 | Sale | Wilson Donald R. Jr. | 10 percent owner | 60,000 0.0677% | $2.62 | $157,200 | -51.72% | |
| 2021-08-03 | Wilson Donald R. Jr. | 10 percent owner | 57,199 0.0647% | $2.65 | $151,406 | -51.52% | ||
| 2021-07-02 | Rice William G. | Chair, President & CEO | 6,081 0.0067% | $3.29 | $19,998 | -57.78% | ||
| 2021-06-22 | Sale | Whitehead Warren | director | 9,600 0.0106% | $3.24 | $31,104 | -55.59% | |
| 2021-06-21 | Sale | Whitehead Warren | director | 15,400 0.0174% | $3.35 | $51,590 | -55.56% | |
| 2020-12-22 | Sale | Whitehead Warren | director | 20,000 0.0234% | $4.06 | $81,200 | -20.52% | |
| 2020-07-10 | Sale | Rice William G. | Chair, President & CEO | 168,891 0.1977% | $6.05 | $1.02M | -16.11% | |
| 2020-07-10 | Sale | Chow Gregory K. | Executive VP & CFO | 126,668 0.1483% | $6.05 | $766,341 | -16.11% | |
| 2020-07-10 | Sale | Marango Jotin | Senior VP, Chief Bus. Officer | 62,835 0.0735% | $6.05 | $380,152 | -16.11% | |
| 2020-07-02 | Sale | Marango Jotin | Senior VP, Chief Bus. Officer | 20,946 0.0238% | $6.34 | $132,793 | -22.08% |
Total: 30
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Rice William G. | Chair, President & CEO | 613252 28.6116% | $2.31M | 10 | 1 | +6.81% |
| Wilson Donald R. Jr. | 10 percent owner | 8888275 414.6869% | $33.42M | 1 | 1 | <0.0001% |
| PLATZER ERICH | director | 505000 23.561% | $1.9M | 3 | 1 | <0.0001% |
| Chow Gregory K. | Executive VP & CFO | 232846 10.8635% | $875,500.96 | 2 | 1 | +46.02% |
| BURGER DENIS R | director | 31671 1.4776% | $119,082.96 | 1 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$8,253,997 | 122 | -53.40% | $11.07M | |
$18,881,323 | 88 | -48.96% | $6.2M | |
$1,226,605 | 43 | -21.28% | $8.11M | |
$523,320 | 24 | 94.37% | $7.24M | |
$746,223 | 23 | -7.24% | $8.84M |
APTO Institutional Investors: Active Positions
| Increased Positions | 5 | +17.24% | 114,320 | +106.47% |
| Decreased Positions | 8 | -27.59% | 69,894 | -65.1% |
| New Positions | 4 | New | 104,266 | New |
| Sold Out Positions | 4 | Sold Out | 65,840 | Sold Out |
| Total Postitions | 26 | -10.34% | 151,796 | +41.38% |
APTO Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Bleichroeder Lp | $307.00 | 4.17% | 83,325 | +83,325 | New | 2024-12-31 |
| Sigma Planning Corp | $87.00 | 1.17% | 23,444 | +10,054 | +75.09% | 2024-12-31 |
| Drw Securities, Llc | $73.00 | 0.99% | 19,759 | 0 | 0% | 2024-12-31 |
| Nations Financial Group Inc, /Ia/ /Adv | $72.00 | 0.98% | 19,500 | +19,500 | New | 2024-12-31 |
| Ubs Group Ag | $7.00 | 0.1% | 1,927 | -2,522 | -56.69% | 2024-12-31 |
| Hrt Financial Lp | $5.00 | 0.07% | 1,437 | +1,437 | New | 2024-12-31 |
| Annandale Capital, Llc | $3.00 | 0.04% | 889 | 0 | 0% | 2024-12-31 |
| Cetera Investment Advisers | $2.00 | 0.03% | 640 | 0 | 0% | 2024-12-31 |
| Two Sigma Securities, Llc | $1.00 | 0.02% | 380 | -634 | -62.52% | 2024-12-31 |
| Morgan Stanley | $1.00 | 0.01% | 183 | -862 | -82.49% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.